Literature DB >> 17268580

The role of biochemical markers of bone turnover in osteoporosis management in clinical practice.

Samuel D Vasikaran, Paul Glendenning, Howard A Morris.   

Abstract

Entities:  

Year:  2006        PMID： 17268580      PMCID： PMC1579290     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN： 0159-8090


× No keyword cloud information.
  27 in total

1.  Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.

Authors:  Peiqi Chen; Julie H Satterwhite; Angelo A Licata; E Michael Lewiecki; Adrien A Sipos; Derek M Misurski; Rachel B Wagman
Journal:  J Bone Miner Res       Date:  2005-01-18       Impact factor: 6.741

2.  Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

Authors:  C H Chesnut; N H Bell; G S Clark; B L Drinkwater; S C English; C C Johnson; M Notelovitz; C Rosen; D F Cain; K A Flessland; N J Mallinak
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

Review 3.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

Authors:  B L Riggs; L J Melton; W M O'Fallon
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

4.  Prediction of rapid bone loss in postmenopausal women.

Authors:  C Christiansen; B J Riis; P Rødbro
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

5.  Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.

Authors:  Harald Dobnig; Adrien Sipos; Yebin Jiang; Astrid Fahrleitner-Pammer; Louis-Georges Ste-Marie; J Christopher Gallagher; Imre Pavo; Jingyuan Wang; Erik F Eriksen
Journal:  J Clin Endocrinol Metab       Date:  2005-04-19       Impact factor: 5.958

6.  Rapid bone loss is associated with increased levels of biochemical markers.

Authors:  P D Ross; W Knowlton
Journal:  J Bone Miner Res       Date:  1998-02       Impact factor: 6.741

7.  The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial.

Authors:  Jackie A Clowes; Nicola F A Peel; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

Authors:  R Eastell; I Barton; R A Hannon; A Chines; P Garnero; P D Delmas
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

9.  Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.

Authors:  J-Y Reginster; S Sarkar; B Zegels; Y Henrotin; O Bruyere; D Agnusdei; J Collette
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

10.  Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk.

Authors:  Somnath Sarkar; Jean-Yves Reginster; Gerald G Crans; Adolfo Diez-Perez; Karen V Pinette; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2003-12-22       Impact factor: 6.741
View more
  5 in total

Review 1.  Relationship between Osteopontin and Bone Mineral Density.

Authors:  A Vancea; O Serban; D Fodor
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

2.  Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.

Authors:  J Nahas-Neto; L M Cangussu; C L Orsatti; F N Bueloni-Dias; P F Poloni; E B Schmitt; E A P Nahas
Journal:  Osteoporos Int       Date:  2018-02-15       Impact factor: 4.507

3.  Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyère; R Rizzoli; V Coxam; B Avouac; T Chevalier; V Fabien-Soulé; J A Kanis; J-M Kaufman; Y Tsouderos; J-Y Reginster
Journal:  Osteoporos Int       Date:  2011-02-25       Impact factor: 4.507

4.  Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.

Authors:  Mei Li; Yan Li; Weimin Deng; Zhenlin Zhang; Zhongliang Deng; Yingying Hu; Weibo Xia; Ling Xu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  Measurement of urinary N-telopeptides and serum C-telopeptides from type I collagen using a lateral flow-based immunoassay.

Authors:  Kyoung Min Lee; Min Ho Lee; Chin Youb Chung; Woo Kyeong Seong; Sang Dae Lee; Moon Seok Park
Journal:  Sensors (Basel)       Date:  2012-12-24       Impact factor: 3.576
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.